» Articles » PMID: 34117641

The First Known Case of Vaccine-induced Thrombotic Thrombocytopenia in Australia

Overview
Journal Med J Aust
Specialty General Medicine
Date 2021 Jun 12
PMID 34117641
Citations 15
Authors
Affiliations
Soon will be listed here.
Citing Articles

Blood Coagulation and Thrombotic Disorders following SARS-CoV-2 Infection and COVID-19 Vaccination.

Sekulovski M, Mileva N, Vasilev G, Miteva D, Gulinac M, Peshevska-Sekulovska M Biomedicines. 2023; 11(10).

PMID: 37893186 PMC: 10604891. DOI: 10.3390/biomedicines11102813.


Heparin-Induced Thrombotic Thrombocytopenia (HITT) and Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT): Similar but Different.

Favaloro E, Pasalic L Methods Mol Biol. 2023; 2663:405-415.

PMID: 37204726 DOI: 10.1007/978-1-0716-3175-1_26.


Incidence of sinus thrombosis with thrombocytopenia-A nation-wide register study.

Hovi P, Palmu A, Nieminen T, Artama M, Jokinen J, Ruokokoski E PLoS One. 2023; 18(2):e0282226.

PMID: 36827275 PMC: 9956025. DOI: 10.1371/journal.pone.0282226.


Understanding thrombosis with thrombocytopenia syndrome after COVID-19 vaccination.

Buoninfante A, Andeweg A, Baker A, Borad M, Crawford N, Dogne J NPJ Vaccines. 2022; 7(1):141.

PMID: 36351906 PMC: 9643955. DOI: 10.1038/s41541-022-00569-8.


Assessment of immunological anti-platelet factor 4 antibodies for vaccine-induced thrombotic thrombocytopenia (VITT) in a large Australian cohort: A multicenter study comprising 1284 patients.

Favaloro E, Clifford J, Leitinger E, Parker M, Sung P, Chunilal S J Thromb Haemost. 2022; 20(12):2896-2908.

PMID: 36107495 PMC: 9828670. DOI: 10.1111/jth.15881.


References
1.
Warkentin T . High-dose intravenous immunoglobulin for the treatment and prevention of heparin-induced thrombocytopenia: a review. Expert Rev Hematol. 2019; 12(8):685-698. DOI: 10.1080/17474086.2019.1636645. View

2.
Favaloro E, Mohammed S, Donikian D, Kondo M, Duncan E, Yacoub O . A multicentre assessment of contemporary laboratory assays for heparin induced thrombocytopenia. Pathology. 2020; 53(2):247-256. DOI: 10.1016/j.pathol.2020.07.012. View

3.
Brodard J, Kremer Hovinga J, Fontana P, Studt J, Gruel Y, Greinacher A . COVID-19 patients often show high-titer non-platelet-activating anti-PF4/heparin IgG antibodies. J Thromb Haemost. 2021; 19(5):1294-1298. PMC: 8013750. DOI: 10.1111/jth.15262. View

4.
Schultz N, Sorvoll I, Michelsen A, Munthe L, Lund-Johansen F, Ahlen M . Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination. N Engl J Med. 2021; 384(22):2124-2130. PMC: 8112568. DOI: 10.1056/NEJMoa2104882. View